Trial intelligence / Profile preview

Indigo naturalis in atopic dermatitis

NCT02669888Phase 2Completed

Sponsor
Chang Gung Memorial Hospital
Start
Oct 2015
Primary completion
Jan 2017
Modality
HM (Herbal Medicine)
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of lindioil in atopic dermatitis (AD), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Percentage change in Eczema Area Severity Index scores at 6 weeks. Started Oct 2015; status: completed.

02

Drugs

lindioil
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT02669888.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02669888.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call